UC partnering in webinar on treatments for young people at risk for substance use disorders
Event Information (passed)
A free webinar, "Tailoring Conversations and Treatment to Adolescents and Young Adults at Risk for Substance Use Disorder" is being offered Thursday, Aug. 8, 2019, from 1 p.m. to 2 p.m. Designed for health care professionals working with youth and young adults in the fields of nursing, pharmacy, medicine, social work, counseling and teaching, the webinar is co-sponsored by the University of Cincinnati College of Allied Health Sciences and College of Education, Criminal Justice and Human Services.
This session is part of the SBIRT webinar series. SBIRT, which stands for screening, brief intervention and referral to treatment, is a comprehensive, integrated public health approach to the delivery of early intervention and treatment services for persons with substance abuse disorders, as well as those who are at risk of developing those disorders. The webinar series is part of the Adolescent SBIRT project which is a collaboration with the National Opinion Research Center at the University of Chicago. Funding is provided by the Conrad N. Hilton Foundation.
Click here for more information about the webinar and here to register.
Additional Contacts
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.